Beyond Biotech - the podcast from Labiotech

Beyond Biotech - the podcast from Labiotech

By LabiotechNewsTech News
Download on the App Store

Beyond Biotech - the podcast from Labiotech episodes

  • Are mitochondrial therapeutics about to go mainstream?

    Mitochondria are famously the powerhouse of the cell, but will mitochondrial therapeutics power the next big mainstream medical breakthrough?

    Klaus Dugi is CEO of Vandria, a biotech that develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. He joins 'Beyond Biotech' to talk cell mitophagy, biotech agility, and innovation in tackling neurodegenerative disease.

    00:42    Introducing Klaus Dugi

    02:51    Lessons learned in top pharma

    05:10    The gap that Vandria seeks to fill

    06:21    Mitochondrial therapeutics

    07:45    Mitophagy inducers and how they work

    14:53    Comparing approaches to treating neurodegenerative diseases

    17:20    Aging, longevity, and healthy life years

    25:26    Challenges ahead

    27:31    Performance enhancement and resilience

    31:15    Towards the mainstream?

    34:35    Looking forward for Vandria

    36:02    Developments to watch out for in mitochondrial therapeutics

    Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! 

    Stay updated by subscribing to our newsletter

    38 min
  • Fighting Alzheimer's with innovative stem cell therapies

    Regeneration Biomedical has developed a new technique to address neurodegenerative diseases like Alzheimer's using stem cell therapy.

    Dr. Christopher Duma, has long been an innovator in neurosurgery using a gamma knife radiosurgery to treat glioblastoma. Now with Regeneration Biomedical, Duma is taking on neurodegenerative diseases with a first-in-human clinical trial where a patient's own stem cells are injected directly into their brain.

    On the podcast this week, we talk with Duma about his career in neurosurgery, the impetus for launching his biotech, the promise of stem cell therapy, and the challenges innovators face moving new therapies through the clinic.

    00:38    Introducing Dr Christopher Duma

    02:44    Advances and breakthroughs in neurosurgery

    05:33    The vision and impetus for Regeneration Biomedical

    10:45    Regeneration Biomedical’s R&D pipeline

    14:12    Milestones ahead

    14:46    Advancing beyond Alzheimer’s Disease

    15:52    Stems cells from fat cells

    19:42    Bypassing the blood-brain barrier

    22:45    Patient recruitment

    24:13    The treatment process

    27:10    The state of stem cell research in the US

    29:29    The challenge of financing innovative research

    32:15    Global stem cell research landscape

    33:14    Controversy in stem cell research

    34:00    Future horizons for Regeneration Biomedical

    37:23    Partnering with top pharma companies

    37:48    Advice for researchers and entrepreneurs


    Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! 

    Stay updated by subscribing to our newsletter

    42 min

About Beyond Biotech - the podcast from Labiotech

From the publisher's feed

Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the…